Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHENYSE:DGXNYSE:DVANYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$588.73-1.6%$556.60$512.12▼$654.62$8.62B0.43101,851 shs101,112 shsDGXQuest Diagnostics$166.43-1.0%$162.84$125.09▼$178.87$18.47B0.921.10 million shs1.53 million shsDVADaVita$142.57-2.8%$159.28$125.64▼$179.60$11.41B0.99791,253 shs1.16 million shsLHLaboratory Co. of America$236.69-1.1%$244.33$191.97▼$258.59$20.03B1.12631,759 shs985,864 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed-1.57%-1.07%+6.38%+6.43%-8.63%DGXQuest Diagnostics-1.01%-3.12%+0.77%+6.64%+28.27%DVADaVita-2.82%+1.67%-17.89%-7.36%+2.39%LHLaboratory Co. of America-1.15%-6.93%-3.45%+2.09%+9.14%Remove AdsMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEChemed4.3198 of 5 stars1.53.03.34.92.83.31.3DGXQuest Diagnostics4.8071 of 5 stars2.33.04.24.72.82.52.5DVADaVita4.0026 of 5 stars2.01.00.04.52.81.73.1LHLaboratory Co. of America4.8137 of 5 stars3.44.02.54.23.22.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 3.00Buy$633.007.52% UpsideDGXQuest Diagnostics 2.67Moderate Buy$178.237.09% UpsideDVADaVita 2.00Hold$166.3316.66% UpsideLHLaboratory Co. of America 2.87Moderate Buy$268.3813.39% UpsideCurrent Analyst Ratings BreakdownLatest LH, DGX, DVA, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/4/2025DGXQuest DiagnosticsCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$185.00 ➝ $185.003/4/2025LHLaboratory Co. of AmericaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$250.00 ➝ $300.002/21/2025DVADaVitaSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$184.002/18/2025DVADaVitaCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold2/18/2025DVADaVitaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$164.00 ➝ $169.002/10/2025LHLaboratory Co. of AmericaPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$240.00 ➝ $260.002/7/2025LHLaboratory Co. of AmericaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$271.00 ➝ $260.002/6/2025LHLaboratory Co. of AmericaJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$275.00 ➝ $290.002/4/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$173.00 ➝ $180.002/3/2025DGXQuest DiagnosticsMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$177.00 ➝ $178.002/3/2025DGXQuest DiagnosticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$166.00 ➝ $170.00(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B3.54$26.28 per share22.40$73.55 per share8.00DGXQuest Diagnostics$9.87B1.87$12.98 per share12.82$61.04 per share2.73DVADaVita$12.82B0.89$18.69 per share7.63$4.95 per share28.80LHLaboratory Co. of America$13.01B1.52$21.34 per share11.09$96.27 per share2.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$272.51M$19.9129.7525.272.1512.69%27.86%19.12%4/23/2025 (Estimated)DGXQuest Diagnostics$871M$7.6921.6415.872.168.80%15.07%6.72%4/22/2025 (Estimated)DVADaVita$936.34M$10.7413.2811.221.077.31%115.48%4.94%5/1/2025 (Estimated)LHLaboratory Co. of America$746M$8.8226.8413.491.715.73%15.29%7.01%4/24/2025 (Estimated)Latest LH, DGX, DVA, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/13/2025Q4 2024DVADaVita$2.14$2.24+$0.10$3.09$3.27 billionN/A2/6/2025Q4 2024LHLaboratory Co. of America$3.40$3.45+$0.05$1.70$3.31 billionN/A1/30/2025Q4 2024DGXQuest Diagnostics$2.19$2.23+$0.04$1.95$2.58 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.000.34%+8.74%10.05%16 YearsDGXQuest Diagnostics$3.201.92%+6.94%41.61%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLaboratory Co. of America$2.881.22%N/A32.65%N/ALatest LH, DGX, DVA, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date1/30/2025DGXQuest Diagnosticsquarterly$0.802.06%4/7/20254/7/20254/21/20252/14/2025CHEChemedquarterly$0.500.36%2/24/20252/24/20253/14/20251/8/2025LHLaboratory Co. of Americaquarterly$0.721.23%2/27/20252/27/20253/12/2025(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.851.81DGXQuest Diagnostics0.821.101.02DVADaVita23.181.261.21LHLaboratory Co. of America0.671.441.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLaboratory Co. of America95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.32%DGXQuest Diagnostics0.79%DVADaVita2.00%LHLaboratory Co. of America0.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,08714.64 million14.55 millionOptionableDGXQuest Diagnostics48,000110.98 million110.73 millionOptionableDVADaVita70,00080.00 million78.40 millionOptionableLHLaboratory Co. of America75,50083.70 million82.93 millionOptionableDVA, LH, DGX, and CHE HeadlinesRecent News About These CompaniesTruist Financial Remains a Buy on Labcorp Holdings (LH)March 12 at 6:28 AM | markets.businessinsider.comPNC Financial Services Group Inc. Acquires 1,431 Shares of Laboratory Co. of America Holdings (NYSE:LH)March 12 at 4:16 AM | marketbeat.comTruist remains bullish on Labcorp after ‘another nice strategic acquisition’March 11 at 5:13 PM | markets.businessinsider.comLabcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services BusinessesMarch 11 at 7:00 AM | prnewswire.comCooke & Bieler LP Has $194.52 Million Position in Laboratory Co. of America Holdings (NYSE:LH)March 11 at 6:56 AM | marketbeat.comLaboratory Co. of America Holdings (NYSE:LH) Shares Acquired by River Road Asset Management LLCMarch 11 at 6:30 AM | marketbeat.comMayar Capital Ltd. Sells 6,339 Shares of Laboratory Co. of America Holdings (NYSE:LH)March 9, 2025 | marketbeat.comAmundi Boosts Holdings in Laboratory Co. of America Holdings (NYSE:LH)March 9, 2025 | marketbeat.comAMF Tjanstepension AB Sells 51,801 Shares of Laboratory Co. of America Holdings (NYSE:LH)March 9, 2025 | marketbeat.comLaboratory Co. of America Holdings (NYSE:LH) Shares Acquired by Candriam S.C.A.March 9, 2025 | marketbeat.comInsider Selling: Laboratory Co. of America Holdings (NYSE:LH) Director Sells 500 Shares of StockMarch 8, 2025 | marketbeat.comKerrii B. Anderson Sells 500 Shares of Laboratory Co. of America Holdings (NYSE:LH) StockMarch 8, 2025 | insidertrades.comDana Investment Advisors Inc. Reduces Stock Position in Laboratory Co. of America Holdings (NYSE:LH)March 8, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stake in Laboratory Co. of America Holdings (NYSE:LH)March 8, 2025 | marketbeat.comAssetmark Inc. Boosts Stock Position in Laboratory Co. of America Holdings (NYSE:LH)March 7, 2025 | marketbeat.com3 Reasons to Avoid LH and 1 Stock to Buy InsteadMarch 6, 2025 | finance.yahoo.comHow Are Institutional Investors Reshaping Laboratory Co. of America Holdings (NYSE:LH)?March 6, 2025 | kalkinemedia.comLaboratory Co. of America (NYSE:LH) Reaches New 12-Month High - Should You Buy?March 6, 2025 | marketbeat.comShould Labcorp Stock Stay in Your Portfolio Right Now?March 6, 2025 | zacks.comVerdence Capital Advisors LLC Boosts Position in Laboratory Co. of America Holdings (NYSE:LH)March 6, 2025 | marketbeat.comLaboratory Co. of America (NYSE:LH) Upgraded at CitigroupMarch 6, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Lands BlackRock Investment—What’s Next for ACHR?By Thomas Hughes | February 13, 2025View Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?Super Micro Computer’s Stock Is About to Make a Super Big AdvanceBy Thomas Hughes | February 12, 2025View Super Micro Computer’s Stock Is About to Make a Super Big Advance3 Chip Stocks Still Trading 50% Below Their 52-Week HighsBy Leo Miller | February 11, 2025View 3 Chip Stocks Still Trading 50% Below Their 52-Week HighsIs Advanced Micro Devices Stock Slide Over?By Thomas Hughes | March 5, 2025View Is Advanced Micro Devices Stock Slide Over?Intel Foundry’s Moment of Truth: Will 18A Deliver?By Jeffrey Neal Johnson | March 6, 2025View Intel Foundry’s Moment of Truth: Will 18A Deliver?DVA, LH, DGX, and CHE Company DescriptionsChemed NYSE:CHE$588.72 -9.78 (-1.63%) Closing price 03/12/2025 03:59 PM EasternExtended Trading$595.90 +7.17 (+1.22%) As of 07:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$166.43 -1.72 (-1.02%) Closing price 03/12/2025 03:58 PM EasternExtended Trading$164.72 -1.71 (-1.03%) As of 07:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$142.57 -4.06 (-2.77%) Closing price 03/12/2025 03:59 PM EasternExtended Trading$141.79 -0.79 (-0.55%) As of 07:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Laboratory Co. of America NYSE:LH$236.69 -2.56 (-1.07%) Closing price 03/12/2025 03:59 PM EasternExtended Trading$236.73 +0.04 (+0.02%) As of 07:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ramaco Resources Pins Hopes on Coal's Untapped Potential Beyond a Market Correction, Moves to Make Now NVIDIA Stock Remains Stunningly Undervalued—Here’s Why Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy 3 Stocks Institutions Are Quietly Dumping Marvell’s 40% Drop Presents a Compelling Buying Opportunity These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Why Wayfair Stock May Be a Hidden Gem for Value Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
